Physician

Thomas W Stone, M.D.

According to 2025 Medicare claims, Thomas Stone, M.D. (NPI: 1528064219) practices ophthalmology in the Louisville/Jefferson County, KY-IN market, with the plurality of this provider's patient population coming from Jefferson, KY. This provider's primary affiliated billing organization is RETINA AND VITREOUS ASSOCIATES OF KENTUCKY PLLC (NPI: 1619949971; TIN: 610918053) and primary practice location at 40205-3338.

Stone's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 879 traditional Medicare patients, billed 34,066 HCPCS/CPT codes, and received $3,086,698 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 597 prescription claims across 313 beneficiaries totaling $25,579 in drug costs, led by Combigan (Brimonidine Tartrate/Timolol). Open Payments data shows 67 records totaling $15,634. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have declined steadily, from $45,376 to $25,579. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.7M$3.4M2015 Medicare payment: $3,273,499 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,946,370 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,891,445 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,910,892 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,972,667 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,029,146 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,386,120 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,911,865 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,556,324 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,086,698 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,31812,711$3,273,499
20161,20011,653$2,946,370
20171,00911,048$2,891,445
201894510,933$2,910,892
20191,04911,728$2,972,667
20201,25212,444$3,029,146
20211,15113,268$3,386,120
202286312,821$2,911,865
202379621,736$2,556,324
202487934,066$3,086,698

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$89K$179K2015 Drug cost: $45,376 (USD; Tot_Drug_Cst)2016 Drug cost: $37,626 (USD; Tot_Drug_Cst)2017 Drug cost: $178,514 (USD; Tot_Drug_Cst)2018 Drug cost: $31,711 (USD; Tot_Drug_Cst)2019 Drug cost: $29,176 (USD; Tot_Drug_Cst)2020 Drug cost: $44,039 (USD; Tot_Drug_Cst)2021 Drug cost: $31,594 (USD; Tot_Drug_Cst)2022 Drug cost: $26,064 (USD; Tot_Drug_Cst)2023 Drug cost: $22,924 (USD; Tot_Drug_Cst)2024 Drug cost: $25,579 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015174472$45,376
2016144393$37,626
2017185429$178,514
2018208484$31,711
2019262526$29,176
2020239580$44,039
2021269629$31,594
2022283504$26,064
2023264474$22,924
2024313597$25,579

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg1751,600$659
67028Injection of drug into eye3071,422$90
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more333658$88
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more433630$61
92134Imaging of retina7702,333$29

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
CombiganBrimonidine Tartrate/Timolol29650$5,720
LumiganBimatoprost11330$2,660
DifluprednateDifluprednate281,268$2,605
Prednisolone AcetatePrednisolone Acetate582,808$2,445
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha2405,220$2,366

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.67$15,634Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Thomas W. Stone, M.D.?

Tedicare shows public-source Medicare data for Thomas W. Stone, M.D. (NPI 1528064219), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Thomas W. Stone, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Thomas W. Stone, M.D.?

Thomas W. Stone, M.D. is linked to RETINA AND VITREOUS ASSOCIATES OF KENTUCKY PLLC (billing NPI 1619949971) in the available physician profile data.

Does Thomas W. Stone, M.D. have Open Payments data?

Thomas W. Stone, M.D. has 67 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.